Alopecia areata (AA) is a common chronic tissue-specific autoimmune disease, resulting in
hair loss, that affects up to 2% of the general population. The exact pathobiology of AA has …

An estimated 20–25% of the population is affected by chronic, non-communicable
inflammatory skin diseases. Chronic skin inflammation has many causes. Among the most …

Alopecia areata (AA) is a relatively common nonscarring hairloss disease characterized by
an autoimmune response to anagen hair follicles (HFs). Accumulated evidence suggests …

Alopecia areata (AA) is a relapsing, chronic, immune-mediated disease characterized by
nonscarring, inflammatory hair loss that can affect any hair-bearing site. AA clinical …

The field of hair disorders is constantly growing. The most important hair diseases are
divided in non‐cicatricial and cicatricial ones. Non‐cicatricial alopecia are more frequent …

Introduction Alopecia areata (AA) is an autoimmune disorder causing sudden, non-scarring
hair loss. There are currently no drugs approved for AA treatment. This study assessed …

Alopecia areata (AA) is a chronic, non-scarring, immune-mediated skin disease that affects
approximately 0.5–2% of the global population. The etiology of AA is complex and involves …

Alopecia areata is a multifactorial autoimmune-based disease with a complex pathogenesis.
As in all autoimmune diseases, genetic predisposition is key. The collapse of the immune …

Alopecia areata is the third most common cause of dermatology consultations in children but
the treatment of paediatric alopecia areata remains challenging. A systematic review of the …

Alopecia areata (AA) is a cell-mediated autoimmune disease in which a cytotoxic T-cell
response against hair follicles occurs. AA has been demonstrated to frequently co-exist with …